Van Andel Institute Researchers Find Potential Drug Target For Aggressive Form Of Lymphoma
A discovery by Van Andel Institute researchers has identified a potential drug target for NK/T-cell lymphoma, a type of cancer responsible for claiming the life of a close friend and fellow researcher.
